Two more patient deaths have been linked to Natrecor during a study of the heart failure drug, reports California-based drug maker Scios Inc.
The two deaths bring the total number of patients who died within one month of being treated with Natrecor to seven. The study was conducted three years ago, but Scios said they only recently learned about the the two other deaths, reports HealthDay
